Prolongation of liver allograft survival by dendritic cells modified with NF-κB decoy oligodeoxynucleotides

Figure 5 Prolongation of survival of liver allograft recipient by NF-κB decoy ODNs-treated DCs. ^bP < 0.001 vs group A, ^dP < 0.001 vs group A, ^fP < 0.001 vs group C, ^hP < 0.001 vs group A, ^jP < 0.001 vs group B, ^lP < 0.001 vs group B, ^aP > 0.05 vs group B.